| scholarly article | Q13442814 |
| P2093 | author name string | Meghan J Elliott | |
| Samuel A Silver | |||
| Anne Tsampalieros | |||
| Zsuzsanna Lichner | |||
| Janine F Farragher | |||
| P2860 | cites work | Central Challenges Facing the National Clinical Research Enterprise | Q24289545 |
| Translational Medicine: A two-way road | Q24802385 | ||
| The meaning of translational research and why it matters | Q28264016 | ||
| OPTN/SRTR 2012 Annual Data Report: kidney | Q30724491 | ||
| Interventions for the prevention of falls in older adults: systematic review and meta-analysis of randomised clinical trials | Q33199828 | ||
| Detection of subclinical tubular injury after renal transplantation: comparison of urine protein analysis with allograft histopathology | Q33290675 | ||
| The impact of measuring patient-reported outcomes in clinical practice: a systematic review of the literature. | Q33313280 | ||
| The Clinical and Translational Science Award (CTSA) Consortium and the translational research model | Q33677840 | ||
| Defining translational research: implications for training | Q33692844 | ||
| Clinical and translational science: from bench-bedside to global village | Q33712799 | ||
| Inpatient rehabilitation specifically designed for geriatric patients: systematic review and meta-analysis of randomised controlled trials | Q33802823 | ||
| A program to prevent functional decline in physically frail, elderly persons who live at home | Q34152921 | ||
| Use of biomarkers and surrogate endpoints in drug development and regulatory decision making: criteria, validation, strategies | Q34192717 | ||
| Setting research priorities for patients on or nearing dialysis | Q34292845 | ||
| Mapping the impact of patient and public involvement on health and social care research: a systematic review | Q34342805 | ||
| International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology | Q34354852 | ||
| Impact of clinical pharmacy services on renal transplant patients' compliance with immunosuppressive medications | Q34419146 | ||
| George Snell's first foray into the unexplored territory of the major histocompatibility complex. | Q34613474 | ||
| Humoral rejection in kidney transplantation: new concepts in diagnosis and treatment | Q34977911 | ||
| The case for knowledge translation: shortening the journey from evidence to effect | Q35139854 | ||
| Inpatient rehabilitation of patients requiring hemodialysis | Q35670249 | ||
| Antibody-mediated rejection in kidney transplantation: a review | Q35915453 | ||
| Exercise training in patients receiving maintenance hemodialysis: a systematic review of clinical trials | Q36222701 | ||
| Prevalence, consequences, and determinants of nonadherence in adult renal transplant patients: a literature review | Q36257235 | ||
| Medication-taking among adult renal transplant recipients: barriers and strategies | Q36520121 | ||
| What's next in translational medicine? | Q36708341 | ||
| Antibody-mediated rejection following renal transplantation | Q36808030 | ||
| Banff 2011 Meeting report: new concepts in antibody-mediated rejection | Q37058043 | ||
| Crossing the research valleys of death: the University of Pittsburgh approach | Q37082077 | ||
| Translational research: from benchside to bedside | Q37174889 | ||
| Defining unacceptable HLA antigens | Q37236970 | ||
| Histocompatibility methods. | Q37418386 | ||
| Renal transplantation across HLA and ABO antibody barriers: integrating paired donation into desensitization protocols | Q37685188 | ||
| The perspectives of kidney transplant recipients on medicine taking: a systematic review of qualitative studies | Q37768279 | ||
| Understanding crossmatch testing in organ transplantation: A case-based guide for the general nephrologist | Q37832763 | ||
| The early diagnosis of acute renal graft dysfunction: a challenge we face. The role of novel biomarkers | Q37857640 | ||
| Current methodologies for detecting sensitization to HLA antigens | Q37888428 | ||
| Urinary tubular biomarkers as potential early predictors of renal allograft rejection. | Q37952332 | ||
| Deceased-donor kidney perfusate and urine biomarkers for kidney allograft outcomes: a systematic review | Q38002312 | ||
| A GPS for finding the route to transplantation for the sensitized patient | Q38019742 | ||
| Identification and therapeutic management of highly sensitized patients undergoing renal transplantation. | Q38022711 | ||
| Histocompatibility considerations for kidney paired donor exchange programs | Q38025850 | ||
| Paired kidney donation: outcomes, limitations, and future perspectives | Q38030183 | ||
| Prevention and self-management interventions are top priorities for osteoarthritis systematic reviews | Q38045144 | ||
| The treatment of acute antibody-mediated rejection in kidney transplant recipients-a systematic review. | Q38049098 | ||
| Transplanting the highly sensitized patient: trials and tribulations | Q38146488 | ||
| Urine proteomics in kidney transplantation | Q38169833 | ||
| Research priority setting in kidney disease: a systematic review. | Q38315823 | ||
| Incidence and impact of de novo donor-specific alloantibody in primary renal allografts | Q39472834 | ||
| Patient involvement in a scientific advisory process: setting the research agenda for medical products | Q39595961 | ||
| KDIGO clinical practice guideline for the care of kidney transplant recipients | Q39936865 | ||
| A national conference to determine research priorities in pediatric solid organ transplantation | Q40113240 | ||
| Practice-based research--"Blue Highways" on the NIH roadmap | Q40249321 | ||
| Significance and biological function of class II MHC molecules. Rous-Whipple Award lecture 1985. | Q41852179 | ||
| Summary of FDA antibody-mediated rejection workshop | Q42598786 | ||
| HLA matching and kidney transplantation: beyond graft survival | Q43629895 | ||
| Quality of life in kidney recipients: comparison of tacrolimus and cyclosporine-microemulsion | Q43975354 | ||
| The first report from the patient outcomes registry for transplant effects on life (PORTEL): differences in side-effects and quality of life by organ type, time since transplant and immunosuppressive regimens | Q44461509 | ||
| Urinary neutrophil gelatinase-associated lipocalin accurately detects acute allograft rejection among other causes of acute kidney injury in renal allograft recipients | Q44705550 | ||
| Neutrophil gelatinase-associated lipocalin and cystatin C could predict renal outcome in patients undergoing kidney allograft transplantation: a prospective study | Q46105884 | ||
| Intravenous immunoglobulin suppression of HLA alloantibody in highly sensitized transplant candidates and transplantation with a histoincompatible organ | Q46321287 | ||
| Quality of life in renal transplant patients over 60 years of age. | Q46449558 | ||
| Pretransplant donor-specific antibodies in cytotoxic negative crossmatch kidney transplants: are they relevant? | Q46630985 | ||
| Kidney NGAL is a novel early marker of acute injury following transplantation | Q46984063 | ||
| Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant. | Q48005087 | ||
| How to increase value and reduce waste when research priorities are set. | Q48099005 | ||
| Compliance and noncompliance in patients with a functioning renal transplant: a multicenter study. | Q50848526 | ||
| Desensitization in HLA-incompatible kidney recipients and survival. | Q51018759 | ||
| Predicting kidney graft failure by HLA antibodies: a prospective trial. | Q51038562 | ||
| Graft and quality of life outcomes in older recipients of a kidney transplant. | Q51930714 | ||
| Kidney paired donation and optimizing the use of live donor organs. | Q51975686 | ||
| Renal transplantation in patients with pre-transplant donor-specific antibodies and negative flow cytometry crossmatches. | Q53528863 | ||
| A study of the quality of life and cost-utility of renal transplantation. | Q53621261 | ||
| Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients. | Q55034268 | ||
| Avoidable waste in the production and reporting of research evidence | Q56028127 | ||
| Urinary Metabolomics for Noninvasive Detection of Borderline and Acute T Cell-Mediated Rejection in Children After Kidney Transplantation | Q57014271 | ||
| Identifying and prioritizing uncertainties: patient and clinician engagement in the identification of research questions | Q57404542 | ||
| Patients' priorities for health research: focus group study of patients with chronic kidney disease | Q57828524 | ||
| Translational research: Crossing the valley of death | Q59063636 | ||
| Desensitization Outcomes: Quantifying and Questioning | Q63244398 | ||
| The significance of a positive flow cytometry crossmatch test in primary kidney transplantation | Q72892027 | ||
| Suppression of HLA-specific alloantibodies by high-dose intravenous immunoglobulins (IVIg). A potential tool for transplantation of immunized patients | Q72892032 | ||
| A high panel-reactive antibody rescue protocol for cross-match-positive live donor kidney transplants | Q73299691 | ||
| Flow cytometric crossmatching in primary renal transplant recipients with a negative anti-human globulin enhanced cytotoxicity crossmatch | Q77309279 | ||
| Supporting medication adherence in renal transplantation (SMART): a pilot RCT to improve adherence to immunosuppressive regimens | Q79848032 | ||
| Successful renal transplantation despite low levels of donor-specific HLA class I antibody without IVIg or plasmapheresis | Q80250028 | ||
| The acceptable mismatch program as a fast tool for highly sensitized patients awaiting a cadaveric kidney transplantation: short waiting time and excellent graft outcome | Q80389325 | ||
| Clinical relevance of pretransplant donor-directed antibodies detected by single antigen beads in highly sensitized renal transplant patients | Q81137752 | ||
| Tools for human leukocyte antigen antibody detection and their application to transplanting sensitized patients | Q81774381 | ||
| Medical Leadership in an Increasingly Complex World | Q84599911 | ||
| Transplant outcomes and economic costs associated with patient noncompliance to immunosuppression | Q84752883 | ||
| A cross-sectional study examining the functional independence of elderly individuals with a functioning kidney transplant | Q85806991 | ||
| Analysis of predictive and preventive factors for de novo DSA in kidney transplant recipients | Q87646078 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 42 | |
| P577 | publication date | 2015-01-01 | |
| P1433 | published in | Canadian journal of kidney health and disease | Q27726098 |
| P1476 | title | Translational research in kidney transplantation and the role of patient engagement | |
| P478 | volume | 2 |
| Q37641415 | Changing Paradigms in the Management of Rejection in Kidney Transplantation: Evolving From Protocol-Based Care to the Era of P4 Medicine |
| Q90679606 | Joint academic and industrial efforts towards innovative and efficient solutions for clinical needs |
| Q49300308 | Prospects for Precision Medicine in Glomerulonephritis Treatment. |
Search more.